Skip to main content
SpringerLink
Log in
Book cover

The Diabetes Textbook pp 357–365Cite as

Measuring Diabetes Quality of Care: Clinical Outcomes, Cost-Effectiveness, and Patient Experience of Care

  • Chapter
  • First Online:

  • 3854 Accesses

Abstract

It is widely recognized worldwide that the quality of care provided to those with diabetes mellitus is far from optimal. In order to improve care in an intentional way, it is of paramount importance to identify key aspects of diabetes care quality to target, develop valid measures of care quality to track changes over time, and use these measures to identify specific types of actions and interventions that are most likely to effectively impact diabetes quality and performance measures. Here we will discuss the strength and weaknesses of current measures of diabetes quality of care and comment on current challenges that face those engaged in this effort, either as developers of quality measures or as users of such measures in care delivery settings or in accountability organizations. For the sake of brevity, we will focus on outpatient care of adults with type 2 diabetes and limit our attention in this chapter to measures of selected clinical outcomes, cost of care, and patient experience of care.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Gregg EW, Li Y, Wang J, Burrows NR, Ali MK, Rolka D, et al. Changes in diabetes-related complications in the United States, 1990–2010. N Engl J Med. 2014;370(16):1514–23.

    Article  CAS  Google Scholar 

  2. Gregg EW, Zhuo X, Cheng YJ, Albright AL, Narayan KM, Thompson TJ. Trends in lifetime risk and years of life lost due to diabetes in the USA, 1985–2011: a modelling study. Lancet Diabetes Endocrinol. 2014;2(11):867–74.

    Article  Google Scholar 

  3. Knowler WC, Fowler SE, Hamman RF, Christophi CA, Hoffman HJ, Brenneman AT, et al. 10-year follow-up of diabetes incidence and weight loss in the diabetes prevention program outcomes study. Lancet. 2009;374(9702):1677–86.

    Article  Google Scholar 

  4. Herman WH, Hoerger TJ, Brandle M, Hicks K, Sorensen S, Zhang P, et al. The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance. Ann Intern Med. 2005;142(5):323–32.

    Article  Google Scholar 

  5. Montori VM, Fernandez-Balsells M. Glycemic control in type 2 diabetes: time for an evidence-based about-face? Ann Intern Med. 2009;150(11):803–8.

    Article  Google Scholar 

  6. Brito JP, Montori VM. ACP Journal Club. Intensive BP control and/or glucose control did not reduce microvascular events in hypertensive type 2 diabetes. Ann Intern Med. 2012;157(8):JC4–7.

    Article  Google Scholar 

  7. O’Connor PJ, Ismial-Beigi F. Near-normalization of glucose and microvascular diabetes complications: data from ACCORD and ADVANCE. Ther Adv Endocrinol Metab. 2011;2(1):17–26.

    Article  Google Scholar 

  8. Gilmer T, O’Connor P, Manning W, Rush W. The cost to health plans of poor glycemic control. Diabetes Care. 1997;20(12):1847–53.

    Article  CAS  Google Scholar 

  9. Desai JR, Vazquez-Benitez G, Xu Z, Schroeder EB, Karter AJ, Steiner JF, et al. Who must we target now to minimize future cardiovascular events and total mortality?: lessons from the surveillance, prevention and management of diabetes mellitus (SUPREME-DM) cohort study. Circ Cardiovasc Qual Outcomes. 2015;8(5):508–16.

    Article  Google Scholar 

  10. O’Connor PJ, Bodkin NL, Fradkin J, Glasgow RE, Greenfield S, Gregg E, et al. Diabetes performance measures: current status and future directions. Diabetes Care. 2011;34(7):1651–9.

    Article  Google Scholar 

  11. Gerstein HC, Miller ME, Genuth S, Ismail-Beigi F, Buse JB, Goff DC Jr, et al. Long-term effects of intensive glucose lowering on cardiovascular outcomes. N Engl J Med. 2011;364(9):818–28.

    Article  CAS  Google Scholar 

  12. Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008;358(24):2560–72.

    Article  CAS  Google Scholar 

  13. Phillips LS, Branch WT, Cook CB, Doyle JP, El-Kebbi IM, Gallina DL, et al. Clinical inertia. Ann Intern Med. 2001;135(9):825–34.

    Article  CAS  Google Scholar 

  14. Ivers N, Jamtvedt G, Flottorp S, Young JM, Odgaard-Jensen J, French SD, et al. Audit and feedback: effects on professional practice and healthcare outcomes. Cochrane Database Syst Rev. 2012;6:Cd000259.

    Google Scholar 

  15. Sperl-Hillen J, Beaton S, Fernandes O, Von Worley A, Vazquez-Benitez G, Parker E, et al. Comparative effectiveness of patient education methods for type 2 diabetes: a randomized controlled trial. Arch Intern Med. 2011;171(22):2001–10.

    Article  Google Scholar 

  16. Spencer-Bonilla G, Quinones AR, Montori VM, International Minimally Disruptive Medicine Workgroup. Assessing the burden of treatment. J Gen Intern Med. 2017;32(10):1141–5.

    Article  Google Scholar 

  17. Boehmer KR, Shippee ND, Beebe TJ, Montori VM. Pursuing minimally disruptive medicine: disruption from illness and health care-related demands is correlated with patient capacity. J Clin Epidemiol. 2016;74:227–36.

    Article  Google Scholar 

  18. Greenfield S, Kaplan SH, Ware JE Jr, Yano EM, Frank HJ. Patients’ participation in medical care: effects on blood sugar control and quality of life in diabetes. J Gen Intern Med. 1988;3(5):448–57.

    Article  CAS  Google Scholar 

  19. Rodriguez-Gutierrez R, Gionfriddo MR, Ospina NS, Maraka S, Tamhane S, Montori VM, et al. Shared decision making in endocrinology: present and future directions. Lancet Diabetes Endocrinol. 2016;4(8):706–16.

    Article  Google Scholar 

  20. McCoy RG, Van Houten HK, Ross JS, Montori VM, Shah ND. HbA1c overtesting and overtreatment among US adults with controlled type 2 diabetes, 2001–13: observational population based study. BMJ. 2015;351:h6138.

    Article  Google Scholar 

  21. Schroeder EB, Xu S, Goodrich GK, Nichols GA, O’Connor PJ, Steiner JF. Predicting the 6-month risk of severe hypoglycemia among adults with diabetes: development and external validation of a prediction model. J Diabetes Complicat. 2017;31(7):1158–63.

    Article  Google Scholar 

  22. Ismail-Beigi F, Moghissi E, Tiktin M, Hirsch IB, Inzucchi SE, Genuth S. Individualizing glycemic targets in type 2 diabetes mellitus: implications of recent clinical trials. Ann Intern Med. 2011;154(8):554–9.

    Article  Google Scholar 

  23. Tarn DM, Heritage J, Paterniti DA, Hays RD, Kravitz RL, Wenger NS. Physician communication when prescribing new medications. Arch Intern Med. 2006;166(17):1855–62.

    Article  Google Scholar 

  24. Ho P, Rumsfeld J, Masoudi F, McClure D, Plomondon M, Steiner J, et al. Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med. 2006;166(17):1836–41.

    Article  Google Scholar 

  25. Desai JR, Sperl-Hillen JM, O’Connor PJ. Patient preferences in diabetes care: overcoming barriers using new strategies. J Comp Eff Res. 2013;2(4):351–4.

    Article  Google Scholar 

  26. Clarke P, Gray A, Adler A, Stevens R, Raikou M, Cull C, et al. Cost-effectiveness analysis of intensive blood-glucose control with metformin in overweight patients with type II diabetes (UKPDS No. 51). Diabetologia. 2001;44(3):298–304.

    Article  CAS  Google Scholar 

  27. Margolis KL, O’Connor PJ, Morgan TM, Buse JB, Cohen RM, Cushman WC, et al. Outcomes of combined cardiovascular risk factor management strategies in type 2 diabetes: the ACCORD randomized trial. Diabetes Care. 2014;37(6):1721–8.

    Article  CAS  Google Scholar 

  28. O’Connor PJ, Sperl-Hillen JM, Fazio CJ, Averbeck BM, Rank BH, Margolis KL. Outpatient diabetes clinical decision support: current status and future directions. Diabet Med. 2016;33(6):734–41.

    Article  Google Scholar 

  29. Anderson RMFJ, Gruppen LD, Funnell MM, Oh MS. The diabetes empowerment scale - short form (DES-SF). Diabetes Care. 2003;26:1641–3.

    Article  Google Scholar 

  30. Welch GWJA, Polonsky WH. The problem areas in diabetes scale: an evaluation of its clinical utility. Diabetes Care. 1997;20:760–6.

    Article  CAS  Google Scholar 

  31. Selby JV, Ray GT, Zhang D, Colby CJ. Excess costs of medical care for patients with diabetes in a managed care population. Diabetes Care. 1997;20(9):1396–402.

    Article  CAS  Google Scholar 

  32. Institute of Medicine. Institute of medicine: guidelines we can trust 2012. Available from: http://iom.edu/Reports/2011/Clinical-Practice-Guidelines-We-Can-Trust.aspx.

  33. Lipska KJ, Hirsch IB, Riddle MC. Human insulin for type 2 diabetes: an effective, less-expensive option. JAMA. 2017;318(1):23–4.

    Article  Google Scholar 

  34. Gilmer TP, Roze S, Valentine WJ, Emy-Albrecht K, Ray JA, Cobden D, et al. Cost-effectiveness of diabetes case management for low-income populations. Health Serv Res. 2007;42(5):1943–59.

    Article  Google Scholar 

  35. Gilmer TP, O’Connor PJ, Sperl-Hillen JM, Rush WA, Johnson PE, Amundson GH, et al. Cost-effectiveness of an electronic medical record based clinical decision support system. Health Serv Res. 2012;47(6):2137–58.

    Article  Google Scholar 

  36. Herman WH, Edelstein SL, Ratner RE, Montez MG, Ackermann RT, Orchard TJ, et al. Effectiveness and cost-effectiveness of diabetes prevention among adherent participants. Am J Manag Care. 2013;19(3):194–202.

    PubMed  PubMed Central  Google Scholar 

Suggested/Further Reading

  • Greenfield S, Kaplan SH, Ware JE Jr, Yano EM, Frank HJ. Patients’ participation in medical care: effects on blood sugar control and quality of life in diabetes. J Gen Intern Med. 1988;3(5):448–57. This pivotal article showed that patient centered care and shared decision-making are linked to better glucose control and better quality of life for diabetes patients. Advances in health informatics now enable shared decision-making to be done at much lower cost and more efficiently than was possible 30-years ago, with potential for substantial further improvement in quality of diabetes care.

    Article  CAS  Google Scholar 

  • O’Connor PJ, Bodkin NL, Fradkin J, Glasgow RE, Greenfield S, Gregg E, et al. Diabetes performance measures: current status and future directions. Diabetes Care. 2011;34(7):1651–9. This article presents an overview of important issues and choices related to measuring diabetes quality of care, with author perspectives representing a wide range of stakeholders.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Center for Chronic Care Innovation, HealthPartners Institute, Minneapolis, MN, USA

    Patrick J. O’Connor & Jo Ann M. Sperl-Hillen

  2. University of California San Diego, San Diego, CA, USA

    Todd P. Gilmer

Authors
  1. Patrick J. O’Connor
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jo Ann M. Sperl-Hillen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Todd P. Gilmer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Patrick J. O’Connor .

Editor information

Editors and Affiliations

  1. Multidisciplinary Diabetes Center, Mexico City, Mexico

    Joel Rodriguez-Saldana

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

O’Connor, P.J., Sperl-Hillen, J.A.M., Gilmer, T.P. (2019). Measuring Diabetes Quality of Care: Clinical Outcomes, Cost-Effectiveness, and Patient Experience of Care. In: Rodriguez-Saldana, J. (eds) The Diabetes Textbook. Springer, Cham. https://doi.org/10.1007/978-3-030-11815-0_22

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-11815-0_22

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-11814-3

  • Online ISBN: 978-3-030-11815-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation